Allergan's total product sales increased by 7.2 percent in the fourth quarter ended Dec. 31 to $1,382.8 million on a net basis, up by 8.2 percent on a currency-neutral basis. Also in terms of constant currencies, sales of specialty pharmaceuticals went up by 10.1 percent, while those of medical devices ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
To continue reading this article register now.